Cetuximab Augments Cytotoxicity with Poly (ADP-Ribose) Polymerase Inhibition in Head and Neck Cancer

por Nowsheen, Somaira, Bonner, James A., LoBuglio, Albert F., Trummell, Hoa, Whitley, Alexander C., Dobelbower, Michael C., Yang, Eddy S.
Publicado 2011

Cellular Model of Warburg Effect Identifies Tumor Promoting Function of UCP2 in Breast Cancer and Its Suppression by Genipin

por Ayyasamy, Vanniarajan, Owens, Kjerstin M., Desouki, Mohamed Mokhtar, Liang, Ping, Bakin, Andrei, Thangaraj, Kumarasamy, Buchsbaum, Donald J., LoBuglio, Albert F., Singh, Keshav K.
Publicado 2011

Recurrent read-through fusion transcripts in breast cancer

por Varley, Katherine E., Gertz, Jason, Roberts, Brian S., Davis, Nicholas S., Bowling, Kevin M., Kirby, Marie K., Nesmith, Amy S., Oliver, Patsy G., Grizzle, William E., Forero, Andres, Buchsbaum, Donald J., LoBuglio, Albert F., Myers, Richard M.
Publicado 2014

TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-po...

por Vaklavas, Christos, Roberts, Brian S., Varley, Katherine E., Lin, Nancy U., Liu, Minetta C., Rugo, Hope S., Puhalla, Shannon, Nanda, Rita, Storniolo, Anna Maria, Carey, Lisa A., Saleh, Mansoor N., Li, Yufeng, Delossantos, Jennifer F., Grizzle, William E., LoBuglio, Albert F., Myers, Richard M., Forero-Torres, Andres
Publicado 2020